Cognition Therapeutics Stock Equity Positions Weight

CGTX Stock  USD 0.63  0.05  8.62%   
Cognition Therapeutics fundamentals help investors to digest information that contributes to Cognition Therapeutics' financial success or failures. It also enables traders to predict the movement of Cognition Stock. The fundamental analysis module provides a way to measure Cognition Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cognition Therapeutics stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Cognition Therapeutics Company Equity Positions Weight Analysis

Cognition Therapeutics' Percentage of fund asset invested in equity instruments. About 80% of global funds and ETFs carry equity instruments on their balance sheet.

Stock Percentage

 = 

% of Equities

in the fund

More About Equity Positions Weight | All Equity Analysis

Cognition Equity Positions Weight Driver Correlations

Understanding the fundamental principles of building solid financial models for Cognition Therapeutics is extremely important. It helps to project a fair market value of Cognition Stock properly, considering its historical fundamentals such as Equity Positions Weight. Since Cognition Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Cognition Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Cognition Therapeutics' interrelated accounts and indicators.
0.980.950.07-1.0-0.780.940.78-0.52-0.950.991.00.911.00.670.91-0.84-0.37-0.38
0.980.990.2-0.99-0.870.960.79-0.55-0.991.00.980.950.970.610.95-0.83-0.52-0.52
0.950.990.26-0.96-0.920.960.8-0.6-1.00.990.950.960.930.60.96-0.84-0.62-0.63
0.070.20.26-0.08-0.40.11-0.040.23-0.290.180.050.350.01-0.50.350.25-0.38-0.39
-1.0-0.99-0.96-0.080.8-0.96-0.770.530.97-0.99-1.0-0.91-0.99-0.65-0.910.840.420.43
-0.78-0.87-0.92-0.40.8-0.8-0.80.70.91-0.87-0.77-0.91-0.74-0.55-0.910.780.820.83
0.940.960.960.11-0.96-0.80.73-0.55-0.960.960.950.90.930.590.9-0.82-0.5-0.51
0.780.790.8-0.04-0.77-0.80.73-0.88-0.770.80.780.850.760.860.85-0.88-0.42-0.44
-0.52-0.55-0.60.230.530.7-0.55-0.880.56-0.57-0.53-0.6-0.5-0.88-0.60.860.570.58
-0.95-0.99-1.0-0.290.970.91-0.96-0.770.56-0.99-0.95-0.96-0.93-0.57-0.960.810.60.61
0.991.00.990.18-0.99-0.870.960.8-0.57-0.990.980.950.970.640.95-0.85-0.51-0.52
1.00.980.950.05-1.0-0.770.950.78-0.53-0.950.980.911.00.670.91-0.85-0.37-0.38
0.910.950.960.35-0.91-0.910.90.85-0.6-0.960.950.910.880.561.0-0.76-0.52-0.54
1.00.970.930.01-0.99-0.740.930.76-0.5-0.930.971.00.880.680.88-0.84-0.34-0.34
0.670.610.6-0.5-0.65-0.550.590.86-0.88-0.570.640.670.560.680.56-0.92-0.28-0.28
0.910.950.960.35-0.91-0.910.90.85-0.6-0.960.950.911.00.880.56-0.76-0.52-0.54
-0.84-0.83-0.840.250.840.78-0.82-0.880.860.81-0.85-0.85-0.76-0.84-0.92-0.760.540.54
-0.37-0.52-0.62-0.380.420.82-0.5-0.420.570.6-0.51-0.37-0.52-0.34-0.28-0.520.541.0
-0.38-0.52-0.63-0.390.430.83-0.51-0.440.580.61-0.52-0.38-0.54-0.34-0.28-0.540.541.0
Click cells to compare fundamentals
Funds with most asset allocated to stocks can be subclassified into many different categories such as market capitalization or investment style.
Competition

According to the company disclosure, Cognition Therapeutics has an Equity Positions Weight of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Did you try this?

Run Idea Analyzer Now

   

Idea Analyzer

Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
All  Next Launch Module

Cognition Fundamentals

About Cognition Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Cognition Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cognition Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cognition Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Cognition Stock Analysis

When running Cognition Therapeutics' price analysis, check to measure Cognition Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cognition Therapeutics is operating at the current time. Most of Cognition Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cognition Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cognition Therapeutics' price. Additionally, you may evaluate how the addition of Cognition Therapeutics to your portfolios can decrease your overall portfolio volatility.